Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
ConclusionsThe CRAFITY score is simple and could be useful for predicting therapeutic outcomes and treatment-related adverse events. (Source: Hepatology International)
Source: Hepatology International - June 24, 2022 Category: Infectious Diseases Source Type: research

Dynamic analysis of serum MMP-7 and its relationship with disease progression in biliary atresia: a multicenter prospective study
ConclusionAs one of the critical factors associated with BA occurrence and progression, serum MMP-7 can be used for early diagnosis of BA and post-KPE MMP-7 level is the earliest prognostic biomarker so far. (Source: Hepatology International)
Source: Hepatology International - June 22, 2022 Category: Infectious Diseases Source Type: research

Associations between intake of starchy and non-starchy vegetables and risk of hepatic steatosis and fibrosis
ConclusionsThese findings support the recommendation to limit starchy vegetable intake and increase non-starchy vegetable intake in CLD prevention, and provide evidence for the potential health benefit from dietary substitution of non-starchy vegetables for starchy vegetables. (Source: Hepatology International)
Source: Hepatology International - June 21, 2022 Category: Infectious Diseases Source Type: research

Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study
ConclusionsGKR was associated better OS than TACE in HCC patients with PVTT, especially for patients with PVTT II-IV.Clinical Trials RegistrationThe study was registered in the Chinese Clinical Trials Registry under the registration number ChiCTR2100051057. (Source: Hepatology International)
Source: Hepatology International - June 21, 2022 Category: Infectious Diseases Source Type: research

Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis
ConclusionsOur novel MB6C and AB6C were stratified by age and provided excellent performance for ruling out HRV, which performed better than B6C and EB6C (expanded B6C) in helping to avoid EGD screening.Clinical trial registration numberChiCTR-DDD-17013845. (Source: Hepatology International)
Source: Hepatology International - June 21, 2022 Category: Infectious Diseases Source Type: research